Keywords = Disease activity
| Number of Articles: 50 | ||||
| 26 | Role of Tenascin-C in Systemic Lupus Erythematosus and Its Association with Disease Activity: Review Article | |||
| Volume 89, Issue 1, October 2022, Page 4839-4841 | ||||
| Shaimaa Mustafa Abdelwahab; Adlia Mohamed Abdelhady; Doaa S Atta; Ghada abdelsalam Ali; Amany M Sediq | ||||
| 27 | RELATION OF ACTIVITY SCORE (DAS28) WITH FUNCTIONAL ASSESSMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS | |||
| Volume 73, Issue 3, September 2022, Page 669-680 | ||||
| Sara M. Gaballa; Naglaa Ali; Dina S. Al-Zifzaf; Mary A. Nassif | ||||
| 28 | Clinical Significance of Prolactin Level in the Assessment of Rheumatoid Arthritis Disease Activity and Severity | |||
| Volume 7, Issue 7, July 2022, Page 1-6 | ||||
| H M.Haggag; S M.Abdel-Monem; A Y.Ali; M Y.Mahgoub | ||||
| 29 | Could ICD10 reflect the effect of Anxiety and Depression on Systemic Lupus Erythematosus Disease Burden? | |||
| Volume 88, Issue 1, July 2022, Page 3369-3373 | ||||
| Ahmed Lotfi; Alyaa Diaa Elmoghazy; Ahmed Mustafa Kamal; Amal Ali Hassan; Mona Hamdy Nasr | ||||
| 30 | Role of Serum Calprotectin in Rheumatoid Arthritis as a Biomarker of Inflammation and its Correlation with Disease Severity | |||
| Volume 28, Issue 1, June 2022, Page 19-26 | ||||
| Doaa Shawky Alashkar; Rawya Ahmed Sakr; Mohamed Ezz El-Deen Mowafy; Maaly Mohamed Mabrouk; Radwa Mostafa Elkhouly | ||||
| 31 | Vitamin D Level and Disease Activity in Children with Juvenile Idiopathic Arthritis | |||
| Volume 2, Issue 1, January 2022, Page 25-31 | ||||
| Emad E. Ghobrial; Huda Marzouk; Mervat Khorshied; Eman Gado | ||||
| 32 | Interleukin 17 role as a biomarker in Systemic Lupus Erythematosus patients. | |||
| Volume 26, Issue 1, January 2022, Page 42-50 | ||||
| Asmaa Tarazan Mostafa; Amany Abbass Abd Allah; Sahar Abo alfotoh Abd Alwahed; Rania Hafez; Safenaz Hussien; Rania Mohamed Bakry | ||||
| 33 | Systemic Lupus Erythematosus in Egyptian Males: A Study of Clinical Features, Serology, Outcome, and Review of Literature | |||
| Volume 89, December, December 2021, Page 3063-3073 | ||||
| NORA YOUSRY ELSAID, M.D.; MARWA NIAZY, M.D.; FATEMA TALAAT ELGENGEHY, M.D.; SALLY S. MOHAMED, M.Sc. | ||||
| 34 | PAIN IN PSORIATIC ARTHRITIS AND ITS RELATION TO THE DISEASE ACTIVITY: CLINICAL AND ULTRASONOGRAPHIC STUDY | |||
| Volume 3, Issue 4, December 2021, Page 53-54 | ||||
| Esraa Mohamed Nasser | ||||
| 35 | High-Mobility Group Box 1 Protein (HMGBl): Role in Lupus Nephritis | |||
| Volume 88, December, December 2020, Page 2421-2429 | ||||
| MERVAT ABO GABAL, M.D.; HANAN FAROUK, M.D.; NORAN O. EL AZIZI, M.D.; MARYAM A. ABDULRAHMAN, M.D.; DALIA GAMAL, M.Sc.; NEAMA M. LOTFY, M.D. | ||||
| 36 | Nailfold Capillaroscopic Changes in Dermatomyositis and Polymyositis Egyptian Patients: Relation to Disease Activity | |||
| Volume 81, Issue 1, October 2020, Page 1292-1298 | ||||
| Shafica Ibrahim Ibrahim; Howaida Elsayed Mansour; Gamer Abdelrahman Azrag; Safaa Abd Elsalam Hussein | ||||
| 37 | CD5+ B Lymphocytes in Systemic Lupus Erythematosus Patients: Relation to Disease Activity | |||
| Volume 88, September, September 2020, Page 1629-1640 | ||||
| NAHED M. SHERIF, M.D.; AHMED M. ELYASAKI, M.D.; SOHA E. IBRAHIM, M.D.; HADEEL TAHA ALI MAHDI, M.Sc. | ||||
| 38 | CD5+ B Lymphocytes in Systemic Lupus Erythematosus Patients: Relation to Disease Activity | |||
| Volume 88, June, June 2020, Page 1055-1063 | ||||
| NAHED MONIR SHERIF, M.D.; AHMED M. ELYASAKI, M.D.;; SOHA E. IBRAHIM, M.D.; HADEEL T. ALI MAHDI, M.Sc. | ||||
| 39 | Serum Interleukin-17 Level in Patients with Rheumatoid Arthritis and its Relation to Disease Activity | |||
| Volume 26, Issue 1, January and February 2020, Page 87-93 | ||||
| Shimaa Essam Atwa; Magda Mostafa Azab; Mervat Soliman Mohamed; mazen Mohamed El sheikh | ||||
| 40 | The Role of Soluble Subtype of the Receptor for Advanced Glycation End Product (sRAGE) in Rheumatoid Arthrirtis Disease Activity and Treatment Follow-up | |||
| Volume 87, June, June 2019, Page 1857-1862 | ||||
| DOAA M.A. EL-ZOGHBY, M.D.; NEHAL EL-FAWY MAHMOUD, M.D.; NERMIN H. EL-GHARBAWY, M.D.; SAFAA M. ABD EL-RAHMAN, M.D. | ||||
| 41 | SERUM INTERLEUKIN-18 AS A NOVEL BIOMARKER FOR DISEASE ACTIVITY OF SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS | |||
| Volume 49, Issue 1, April 2019, Page 145-152 | ||||
| AMAL S. ELSHAL; MOHAMED H. SHERIF; AMAL B. ABDULSATTAR; FATMA ELZAHRAA E. GOUDA | ||||
| 42 | Serum Interleukin-33 in Rheumatoid Arthritis and its Relation to Disease Activity | |||
| Volume 21, Issue 2, October 2018, Page 132-139 | ||||
| Mai S. Shalaby; Mona I. Salama; Rasha E. Badr; Amany M. Hassan; Amal S. Ahmed; Aziza S. Omar | ||||
| 43 | Sexual dysfunction in women in the reproductive age with rheumatoid arthritis: A case-control study | |||
| Volume 8, Issue 2, June 2018, Page 43-52 | ||||
| Hussein Ghanem; Ahmed Ragab; Nashaat Nabil; Shimaa Hamdy; Islam Fathy | ||||
| 44 | The Use of Interleukin-22 as a Novel Marker of Disease Activity in Female Patients with Rheumatoid Arthritis | |||
| Volume 22, Issue 1, January 2018, Page 143-153 | ||||
| Laila Mohamed Yousef; Sahar Aboalftoh; Tamer Mohamed Abdel-Latef; Khalid Elsayed Ali | ||||
| 45 | The Relationship of Serum 25-Hydroxyvitamin D Levels with Disease Activity in Upper Egyptian Patients with Rheumatoid Arthritis | |||
| Volume 22, Issue 1, January 2018, Page 192-198 | ||||
| Abdullah Ahmed; Ahmed Allam | ||||
| 46 | Quality of life and Disease activity among Patients with Systemic Lupus Erythematous. | |||
| Volume 5, Issue 11, August 2017, Page 74-83 | ||||
| Anaam Mohammed Hassan; Shalaba El-Sayed Abo Zead; Essam Ahamed Mohamed Abda | ||||
| 47 | Quality of Life and It's Relation to Disease Activity in Egyptian Patients with Systemic Lupus Erythematosus | |||
| Volume 3, Issue 2, July 2015, Page 95-104 | ||||
| Abeer Shahba; Ibrahim Ali Kabbash | ||||
| 48 | Serum Prolactin in Patients with Rheumatoid Arthritis and its Association with Disease Activity | |||
| Volume 3, Issue 1, January 2015, Page 55-60 | ||||
| Dalia Fayez; Reem Habeeb; Sameh Hassan; Noha Abdelfatah | ||||
| 49 | Serum Levels of Soluble Fractalkine in Patients with Systemic Lupus Erythematosus | |||
| Volume 33, Issue 1, June 2013, Page 73-84 | ||||
| Dalia Shaheen; Hisham Habib; Doaa Shahin | ||||
| 50 | Role of Interleukin-18, S-adenosylmethionine and SAdenosylhomocysteine as Cardiovascular Risk Factors in Patients with Systemic Lupus Erythematosus | |||
| Volume 30, Issue 1, December 2010, Page 53-72 | ||||
| Ayman El Samanoudy; Adel Zalata; Abd El Hameed Metwali; Fayez el Kenawy; Adel Elbadrawy | ||||
| | ||||
View on SCiNiTO
